Library docking for Cannabinoid-2 Receptor ligands

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Pharmacology

Background:

• G protein-coupled receptors (GPCRs), including cannabinoid receptors, are key therapeutic targets.
• Structure-based drug design offers a powerful approach for targeting GPCRs.
• Previous efforts targeting the CB1 receptor yielded potent but non-selective ligands.

Purpose of the Study:

• To explore library docking strategies using the CB2 receptor as a model system.
• To identify subtype-selective ligands for the CB2 receptor.
• To investigate the impact of library size and receptor state on docking outcomes.

Main Methods:

• Structure-based drug design utilizing the CB2 receptor crystal structure.
• Large-scale virtual screening (library docking) of up to 2.6 billion molecules.
• Cryo-electron microscopy (Cryo-EM) for structural validation.
• Structure-based optimization of identified ligands.

Main Results:

• Targeting polar, orthosteric residues of CB2 led to subtype-selective ligands.
• Increased library size significantly improved docking hit rate and ligand affinity.
• Docking against different receptor states did not reliably predict agonist or inverse agonist activity.
• Cryo-EM structures confirmed the accuracy of docking predictions for novel agonists.
• Structure-based optimization yielded substantial potency improvements (10-140 fold).
• Eight diverse ligand families with nanomolar potency were discovered.

Conclusions:

• Structure-based design targeting specific interactions is effective for discovering selective GPCR ligands.
• Large virtual libraries are crucial for identifying high-affinity compounds.
• The CB2 receptor remains a viable target for developing novel therapeutics.
• This study provides a framework for future structure-based drug discovery campaigns against GPCRs.